IGE BINDING PROTEIN--A MULTIFUNCTIONAL ANIMAL LECTIN

IGE结合蛋白--一种多功能动物凝集素

基本信息

  • 批准号:
    2061370
  • 负责人:
  • 金额:
    $ 20.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1984
  • 资助国家:
    美国
  • 起止时间:
    1984-04-01 至 1997-03-31
  • 项目状态:
    已结题

项目摘要

The focus of this project is on IgE-binding protein (epsilon-BP) with emphasis on its modulatory role on mast cell functions. Epsilon-BP is a 31,000 Mr protein identified in rat basophilic leukemia (RBL) cells and is now known as soluble lectin designated with different names by other laboratories and appears to have multiple functions. The protein has wide tissue distribution, is found on the cell surface and also secreted under certain conditions. Epsilon-BP has specificity for distinct oligosaccharide structures that have a terminal galactose not masked by sialic acids and it functions at least bivalently. In addition to binding IgE, epsilon-BP binds to surfaces of various cell types, including mast cells. First, the molecular basis for multivalency of epsilon-BP will be elucidated. We have evidence that epsilon-BP has a tendency to self-associate through intermolecular interactions involving the amino-- terminal domain, resulting in dimers or oligomers. This property of epsilon-BP will be further investigated, including equilibrium ultracentrifugation analysis and binding to lactosyl-Sepharose 4B containing varying densities of lactose. Another explanation for bivalency of epsilon-BP is the formation of a dimer through an inter-molecular disulfide linkage. The molecular mechanism for the covalent dimerization of epsilon-BP will be investigated. Second, cell surface glycoprotein ligands for epsilon-BP will be identified. Preliminary studies indicate that epsilon-BP is attached to glycoconjugates on the surface of mast cells and only a small number of different glycoproteins species on RBL cell surface are recognized by epsilon-BP. Significantly, one of these glycoproteins is the high affinity IgE receptor (Fc-epsilon-RI). We will focus on isolation and characterization of another epsilon-BP-reactive Mr 150,00 glycoprotein. We will then investigate possible variation in epsilon-BP recognition of FC-epsilon-RI on mast cells at various differentiation stages or activation status. Third, the function of epsilon-BP as a multifunctional modulator molecule will be established. Having demonstrated epsilon-BP's multivalent property and recognition of cell surface glycoproteins, especially Fc-epsilon-RI, we propose that this lectin has the potential to modulate cellular functions of mast cells mediated by these glycoproteins. We have already shown that epsilon-BP potentiates Fc-epsilon-RI-mediated mast cell activation. We will further substantiate this modulator role of epsilon-BP and investigate the mechanism for the observed potentiating effect.
本项目的重点是研究与之相关的ige结合蛋白(epsilon-BP)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FU-TONG LIU其他文献

FU-TONG LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FU-TONG LIU', 18)}}的其他基金

DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
特应性皮炎非人灵长类动物模型的开发
  • 批准号:
    8357349
  • 财政年份:
    2011
  • 资助金额:
    $ 20.09万
  • 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
  • 批准号:
    7785910
  • 财政年份:
    2010
  • 资助金额:
    $ 20.09万
  • 项目类别:
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
特应性皮炎非人灵长类动物模型的开发
  • 批准号:
    8172632
  • 财政年份:
    2010
  • 资助金额:
    $ 20.09万
  • 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
  • 批准号:
    8401847
  • 财政年份:
    2010
  • 资助金额:
    $ 20.09万
  • 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
  • 批准号:
    8206814
  • 财政年份:
    2010
  • 资助金额:
    $ 20.09万
  • 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
  • 批准号:
    8013555
  • 财政年份:
    2010
  • 资助金额:
    $ 20.09万
  • 项目类别:
Regulation of Skin Wound Epithelialization by Galectin-3
Galectin-3 调节皮肤伤口上皮化
  • 批准号:
    7470573
  • 财政年份:
    2007
  • 资助金额:
    $ 20.09万
  • 项目类别:
Regulation of Skin Wound Epithelialization by Galectin-3
Galectin-3 调节皮肤伤口上皮化
  • 批准号:
    7315928
  • 财政年份:
    2007
  • 资助金额:
    $ 20.09万
  • 项目类别:
IMMUNOLOGIC BASIS OF ANTI-IGE THERAPY
抗 IGE 治疗的免疫学基础
  • 批准号:
    6975663
  • 财政年份:
    2004
  • 资助金额:
    $ 20.09万
  • 项目类别:
Validation of Galectin-3 as a Target in Cancer Therapy
Galectin-3 作为癌症治疗靶点的验证
  • 批准号:
    6640748
  • 财政年份:
    2002
  • 资助金额:
    $ 20.09万
  • 项目类别:

相似海外基金

Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
  • 批准号:
    23H02361
  • 财政年份:
    2023
  • 资助金额:
    $ 20.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : GNT1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 20.09万
  • 项目类别:
    Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : 1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 20.09万
  • 项目类别:
    Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9300976
  • 财政年份:
    2015
  • 资助金额:
    $ 20.09万
  • 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9920805
  • 财政年份:
    2015
  • 资助金额:
    $ 20.09万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8900121
  • 财政年份:
    2012
  • 资助金额:
    $ 20.09万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8225814
  • 财政年份:
    2012
  • 资助金额:
    $ 20.09万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8699511
  • 财政年份:
    2012
  • 资助金额:
    $ 20.09万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8525355
  • 财政年份:
    2012
  • 资助金额:
    $ 20.09万
  • 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
  • 批准号:
    9115537
  • 财政年份:
    1991
  • 资助金额:
    $ 20.09万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了